Drimva

GSK

SERM Senior Scientific Director, Oncology

$218K–$363K

USA - Pennsylvania - Upper Providence +3 · Hybrid (Remote & On-site) · Director · Full-time · Posted Oct 27, 2026

Location
USA - Pennsylvania - Upper Providence
USA - Massachusetts - Waltham
Rockville Tower Oaks Blvd
Durham Blackwell Street
Experience
5+ years in pharmacovigilance, drug safety, or a related safety evaluation role in the pharmaceutical or biotech industry.
Education
Degree in a health or life sciences discipline (e.g., Bachelor of Science, PharmD, MD, PhD, or equivalent).

About the job

Leads safety evaluation and risk management for oncology assets in clinical development, identifying and communicating risks to support benefit-risk decisions and protect patients.

What you'll do

  • Lead pharmacovigilance, signal assessment, and risk mitigation for oncology assets and clinical trials.
  • Contribute safety analyses and regulatory submission materials, and present recommendations to governance committees and regulators.
  • Represent SERM on cross-functional teams, lead responses to complex safety issues, and mentor junior colleagues.

What they ask for

  • Degree in a health or life sciences discipline (e.g., Bachelor of Science, PharmD, MD, PhD, or equivalent).
  • Practical experience in signal detection, safety surveillance, and risk management across clinical development and post-marketing.
  • Knowledge of global pharmacovigilance requirements and drug development processes.
  • Strong clinical or scientific judgment and experience interpreting clinical and safety data.

Nice to have

  • Advanced degree (PharmD, PhD, MD) or equivalent clinical qualification; 10 or more years of pharmacovigilance or medical safety experience.
  • Experience preparing regulatory safety documents, regulatory interactions, therapeutic-area safety leadership, cross-functional matrix leadership, or inspection and audit readiness.

Pay

$217,800 to $363,000 USD annual base salary

Tools

INDs, DSURs, IBs

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 6, 2026 (UTC)